or
forgot password

    • cancer clinical trials in albany, NY

    • Safety and Immunogenicity Study of MEDI-517 (GSK 580299) With or Without Adjuvant in Healthy Adult Females
    GSK Clinical Trials Call Center
    Albany, New York 12208
    Prophylaxis HPV-16/18 Infections and Cervical Neoplasia
    Dose-Comparison Study to Evaluate the Safety and Immunogenicity of MEDI-517 (GSK 580299) in Healthy Adult Females
    GSK Clinical Trials Call Center
    Albany, New York 12208
    Prophylaxis HPV-16/18 Infections and Cervical Neoplasia
    A Phase I/II Study of HE3235 in Patients With Prostate Cancer

    Albany, New York 12208
    Prostate Cancer
    Safety and Efficacy Study of Switching From Epzicom to Truvada
    Upstate Infectious Diseases Associates
    Albany, New York 23309
    HIV Infection
    A Study of Tor Kinase Inhibitor in Advanced Tumors
    Research Site
    Albany, New York
    Solid Tumors
    Phase II Trial of BIBW 2992 (Afatinib) in Genetically Pre-screened Cancers With EGFR and/or HER2 Gene Amplification.
    1200.26.4 Boehringer Ingelheim Investigational Site
    Albany, New York
    Neoplasms
    RDEA119 and Sorafenib Combination Dose Escalation Study
    New York Oncology Hematology, PC
    Albany, New York 12208
    Advanced Cancer
    A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer

    Albany, New York 12208
    Carcinoma, Renal Cell, Kidney Neoplasms, Kidney Diseases
    A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

    Albany, New York 12208
    Carcinoma, Ovarian Cancer, Ovarian Diseases, Ovarian Neoplasms
    Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer
    Research Site
    Albany, New York
    Cancer, Carcinoma, Castrate-Resistant Prostate Cancer, Prostate Cancer, Tumors
    Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)
    Albany Regional Cancer Center

    Trial Locations
    Albany Regional Cancer Center
    The Urological Institute of Northeastern New York
    Metastatic Androgen Independent Prostate Cancer
    ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
    Pulmonary Critical Care Servcies
    Albany, New York
    Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension
    Observational Study of Subjects Having Routine Recurrence Screening for Bladder Cancer
    Community Care Physicians

    Trial Locations
    Community Care Physicians
    Capital Regional Urological Surgeons
    Bladder Cancer Recurrence
    A Study of Degarelix in Patients With Prostate Cancer
    The Urological Institute of NE NY, CCP
    Albany, New York
    Prostate Cancer
    A Trial of Degarelix in Patients With Prostate Cancer
    Capital Region Urological Surgeons and Research Associates
    Albany, New York
    Prostate Cancer
    Carboplatin and Paclitaxel Combined With Cetuximab and/or Cixutumumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    New York Oncology Hematology PC -Albany Medical Center

    Trial Locations
    New York Oncology Hematology PC -Albany Medical Center
    New York Oncology Hematology PC - Albany
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors

    Albany, New York 12208
    Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas)
    Immune Response Following Treatment of Resectable Renal Cell Carcinoma at Intermediate Risk of Recurrence
    Community Care Physicians
    Albany, New York 12208
    Renal Cell Carcinoma
    Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer
    Research Site
    Albany, New York
    Neoplasms, Breast Neoplasms, Breast Cancer
    A Treatment-Option Study of Brentuximab Vedotin in Patients With Progression of Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma

    Albany, New York 12208
    Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    The Capital Region Medical Research Foundation, Inc.
    Albany, New York 12208
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium
    A Study of RO5185426 in Patients With Metastatic Melanoma

    Albany, New York 12208
    Malignant Melanoma
    A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
    Research Site
    Albany, New York
    Glioblastoma Multiforme
    A Study of ChemoFx® Chemoresponse Assay in Solid Tumors - ChemoFx® Registry Study
    Albany Thoracic & Esophageal Surgery
    Albany, New York 12208
    Solid Organ Tumors
    First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

    Albany, New York 12208
    Bladder Cancer
    A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.
    Northeast Urogynecology

    Trial Locations
    Northeast Urogynecology
    The Urologic Institute of Northeastern New York - Community Care Physicians, PC
    Urinary Bladder, Overactive
    Phase II, Dose Finding Study of GTx-758
    GTx Investigative Site
    Albany, New York 12208
    Prostate Cancer
    A Long-term Extension Study of PCI-32765 (Ibrutinib)

    Albany, New York 12208
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-cell Lymphoma
    A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer

    Albany, New York 12208
    Low-grade Serous Ovarian Cancer, Low-grade Serous Fallopian Tube Cancer, Low-grade Serous Peritoneal Cancer